Boyer Andrew S
- SEC CIK
- 0001239546
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Executive Vice Presidentas of Sep 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boyer Andrew S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 (view filing) | Aug 20 | 2 days | Boyer Andrew SExecutive Vice President | SSaleClass A Common Stock | −279.2K | $9.38 | −$2.62M | −64.7%152.4K after | |
| Aug 13, 2025 (view filing) | Aug 12 | 1 day | Boyer Andrew SExecutive Vice President | SSaleClass A Common Stock | −33.4K | $9.05 | −$302.6K | −11.5%256.7K after | |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Boyer Andrew SExecutive Vice President | SSaleClass A Common Stock | −125.0K | $8.89 | −$1.11M | −30.1%290.1K after | |
| Aug 16, 2024 (view filing) | Aug 14-15 | 2 days | Boyer Andrew SExecutive Vice President | SSaleClass A Common Stock | −62.7K | $7.84 | −$491.4K | −19.6%256.7K after | 2 lots |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | Boyer Andrew SExecutive Vice President | SSaleClass A Common Stock | −29.3K | $4.13 | −$121.0K | −10.7%244.7K after |